Literature DB >> 7205320

The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis.

B R Deane, P L Lantos.   

Abstract

The process of vascularisation was studied in transplanted astrocytomas in BD-IX rats. The development of blood vessels was followed from the earliest signs of angiogenesis throughout tumour growth. On the basis of tumour vasculature, 3 consecutive stages of tumour growth could be distinguished; avascular, early vascular and late vascular. The tumours grew to a diameter of about 1 mm during the avascular stage after which new capillary sprouts began to penetrate the tumours. This resulted in an homogeneous vasculature of small immature capillaries up to about 5 micrometers in diameter characteristic of the early vascular growth stage. During this stage the tumours reached a diameter of about 4 mm and their vasculature consisted of capillaries similar to those seen in embryological cerebral vascularisation. During the subsequent late vascular stage of growth, continued endothelial proliferation led to an increase in blood vessel diameter up to 50 micrometers in some cases. The vessels varied in shape and size; this vascular pleomorphism and the abnormal morphological features associated with glioma vasculature were typical of the late vascular stage.

Entities:  

Mesh:

Year:  1981        PMID: 7205320     DOI: 10.1016/0022-510x(81)90188-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  32 in total

1.  Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

Authors:  P Vajkoczy; M D Menger; B Vollmar; L Schilling; P Schmiedek; K P Hirth; A Ullrich; T A Fong
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 2.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

Review 3.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 4.  Vascular microenvironment in gliomas.

Authors:  P Vajkoczy; M D Menger
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

5.  Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier.

Authors:  D Zagzag; S Brem; F Robert
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

6.  Effects of glucocorticoid and chemotherapy on the peritumoral edema and astrocytic reaction in experimental brain tumor.

Authors:  J Jamshidi; T Yoshimine; Y Ushio; T Hayakawa
Journal:  J Neurooncol       Date:  1992-03       Impact factor: 4.130

7.  Periphery of ethylnitrosourea-induced spinal gliomas in rats with special reference to the vascular structure.

Authors:  H Kroh
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma.

Authors:  Peter S LaViolette; Mitchell K Daun; Eric S Paulson; Kathleen M Schmainda
Journal:  J Neurooncol       Date:  2013-11-29       Impact factor: 4.130

9.  Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy.

Authors:  D Schiffer; M T Giordana; R Soffietti; R Sciolla
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

10.  Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology.

Authors:  Gregory A Christoforidis; Allahyar Kangarlu; Amir M Abduljalil; Petra Schmalbrock; Abhik Chaudhry; Alan Yates; Donald W Chakeres
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.